From: Non-coding RNAs: a key to future personalized molecular therapy?
Blood malignancy | miRNA | Regulation | References |
---|---|---|---|
CLL | miR-15a miR-16-1, miR-181a, let-7a, miR-30d, miR-150, miR-92 | Downregulation | |
Pediatric Burkitt's lymphoma, Hodgkin's lymphoma, diffuse large B cell lymphoma | miR-155, miR-17-92 | Upregulation | |
Hodgkin's disease, Burkitt lymphoma cells | miR-9, let-7a | Upregulation | |
B cell malignancies | miR-143, miR-145 | Downregulation | [75] |
AML | miR-127, miR-154, miR-299, miR-323, miR-368, miR-370 | Upregulation | |
AML | miR-221, miR-222 | Downregulation | |
Hematopoietic malignancies | miR-203 | Downregulation | [33] |